Status:
RECRUITING
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Lead Sponsor:
University Medical Center Goettingen
Collaborating Sponsors:
Charite University, Berlin, Germany
Wuerzburg University Hospital
Conditions:
DLBCL - Diffuse Large B Cell Lymphoma
Eligibility:
All Genders
18-85 years
Brief Summary
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of ...
Detailed Description
Observational study of 500 recruited and 300 evaluable patients with de novo large cell B Cell lymphoma, age 18-80. Standard guideline recommended treatment by treating physicians discretion. Collecti...
Eligibility Criteria
Inclusion
- Histological diagnosis of DLBCL\&LBCL
- Planned treatment with guideline-based first-line therapy
- Patient's consent
- All genders, Patient age ≥ 18 years
- Ability to consent
Exclusion
- Treatment with R-CHOP/-like regimens already started
- Relationship of dependence/ direct employment with the investigator
- Active HIV-infection
- Presence history of other active cancers (with the exception of basal cell carcinoma of the skin)
Key Trial Info
Start Date :
June 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06526065
Start Date
June 20 2024
End Date
June 1 2029
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsmedizin Göttingen
Göttingen, Lower Saxony, Germany, 37075